CPT code 65920 covers surgical removal of previously implanted material from the anterior segment of the eye, such as explantation of an artificial lens. This code is clinically important because explantation procedures address complications like implant dislocation, infection, or visual disturbance and can have significant implications for surgical planning, resource use, and patient outcomes across the country.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. The publication provides a national perspective on billing and clinical context for anterior segment implant removals, highlighting coding definitions, typical sites of service, and the clinical scenarios that most commonly prompt explantation.

Readers will learn practical benchmarks and reimbursement context where available, common billing considerations tied to the procedure, and relevant clinical context to understand when 65920 is used. The report also summarizes typical service settings and the procedural scope captured by the code. Data not available in the input will be clearly noted when specific payer policies, utilization metrics, or diagnosis mapping are absent.